A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST) Meeting Abstract
| Authors: | Aghajanian, C.; Washington, C.; Moore, K.; Krivak, T.; Mathews, C.; Philip, T.; Konecny, G.; Fleming, G.; Martin, N.; Smith, G.; Harrop, B.; Millward, H.; Skelton, S.; Little, N.; Headley, D.; Smith, I.; Konstantinopoulos, P. |
| Abstract Title: | A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST) |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer |
| Journal Title: | Gynecologic Oncology |
| Volume: | 190 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Mar 15-18 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-11-01 |
| Start Page: | S296 |
| End Page: | S297 |
| Language: | English |
| ACCESSION: | WOS:001330731400431 |
| DOI: | 10.1016/j.ygyno.2024.07.443 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2145 -- Source: Wos |
